Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug
US8710091B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2010 |
| Grant date | Apr 29, 2014 |
| Priority date | — |
| Expiry date | Apr 16, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/76
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application relates to novel imidazolidine-2,4-dione derivatives of the general formula (I), where R1, R2, R3, R4, X, and Y are variables. Said materials have an antiproliferative activity. They are particularly useful for treating pathological conditions and diseases, such as cancer, that are linked to abnormal cell proliferation. The invention also relates to pharmaceutical compositions containing said materials and to the use thereof for preparing a drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.